Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 4

2(33.3%)

6Total

N/A(4)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07240038Recruiting

Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)

Role: collaborator

NCT07179874Not ApplicableCompleted

Remote Ischemic Preconditioning to Prevent Contrast-Induced Kidney Injury in Diabetic Patients (PRINCES)

Role: collaborator

NCT03696654Not ApplicableActive Not Recruiting

High Blood Pressure in Paediatric Patients With Sleep Disorder Breathing.

Role: collaborator

NCT05044403Not ApplicableRecruiting

Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.

Role: collaborator

NCT02333292Completed

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions

Role: collaborator

NCT02034851Completed

Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection

Role: collaborator

NCT01803191Phase 4Completed

Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy

Role: collaborator

NCT02464592Not ApplicableCompleted

Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study

Role: collaborator

NCT01785758Phase 4Completed

Efficacy and Safety of Sugammadex in Renal Diseased Patients

Role: collaborator

All 9 trials loaded